Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Working Capital/Sales

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023
   Working Capital/Sales(x) 1.930.791.51

What is the latest Working Capital/Sales ratio of GENPHARMASEC ?

The latest Working Capital/Sales ratio of GENPHARMASEC is 1.93 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.93
Mar20240.79
Mar20231.51

How is Working Capital/Sales of GENPHARMASEC Trending?

Years Working Capital/Sales % Change
Mar2025 1.93
144.30
Mar2024 0.79
-47.68
Mar2023 1.51 -

Other Financial Ratios of GENPHARMASEC


Compare Working Capital/Sales ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹64.8 Cr 0.9% -13.3% -60.3% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹6,953.2 Cr -0.7% -6% -21% Stock Analytics
KIRI INDUSTRIES ₹2,855.3 Cr 0.6% -21.4% -16.4% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,556.8 Cr -2.8% -9.7% -41% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,045.8 Cr -2.5% -15% 12.2% Stock Analytics
BODAL CHEMICALS ₹604.7 Cr 3.3% -10.3% -25.6% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

0.9%

-13.3%

-60.3%

SENSEX

0.2%

-3.6%

8.6%


You may also like the below Video Courses